Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 292

1.

Interleukin-15 as an activator of natural killer cell-mediated antiviral response.

Gosselin J, TomoIu A, Gallo RC, Flamand L.

Blood. 1999 Dec 15;94(12):4210-9.

2.

Interleukin 15-mediated induction of cytotoxic effector cells capable of eliminating Epstein-Barr virus-transformed/immortalized lymphocytes in culture.

Sharif-Askari E, Fawaz LM, Tran P, Ahmad A, Menezes J.

J Natl Cancer Inst. 2001 Nov 21;93(22):1724-32.

PMID:
11717333
3.

Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity.

Reiter Z.

Crit Rev Immunol. 1993;13(1):1-34. Review. Erratum in: Crit Rev Immunol 1993;13(2):193.

PMID:
8466640
4.
5.

Human herpesvirus-6 enhances natural killer cell cytotoxicity via IL-15.

Flamand L, Stefanescu I, Menezes J.

J Clin Invest. 1996 Mar 15;97(6):1373-81.

7.

Up-regulation of NK cytotoxic activity via IL-15 induction by different viruses: a comparative study.

Fawaz LM, Sharif-Askari E, Menezes J.

J Immunol. 1999 Oct 15;163(8):4473-80.

8.

Enhancement of natural killer and antibody-dependent cytolytic activities of the peripheral blood mononuclear cells of HIV-infected patients by recombinant IL-15.

Loubeau M, Ahmad A, Toma E, Menezes J.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Nov 1;16(3):137-45.

PMID:
9390564
10.

Enhancement of natural killer cell cytotoxicity by the human herpesvirus-7 via IL-15 induction.

Atedzoe BN, Ahmad A, Menezes J.

J Immunol. 1997 Nov 15;159(10):4966-72.

PMID:
9366423
11.

Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).

Gattoni A, Parlato A, Vangieri B, Bresciani M, Derna R.

Clin Ter. 2006 Jul-Aug;157(4):377-86. Review. Retraction in: Clin Ter. 2008 May-Jun;159(3):207.

PMID:
17051976
12.

Release of lymphokines after Epstein Barr virus infection in vitro. I. Sources of and kinetics of production of interferons and interleukins in normal humans.

Lotz M, Tsoukas CD, Fong S, Dinarello CA, Carson DA, Vaughan JH.

J Immunol. 1986 May 15;136(10):3636-42.

PMID:
3009608
13.

Alternative mechanisms of natural killer cell activation during herpes simplex virus infection.

Paya CV, Schoon RA, Leibson PJ.

J Immunol. 1990 Jun 1;144(11):4370-5.

PMID:
2160501
14.

Natural killer (NK) cells prevent virus production in cell culture.

Baraz L, Khazanov E, Condiotti R, Kotler M, Nagler A.

Bone Marrow Transplant. 1999 Jul;24(2):179-89.

15.

Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function.

Mailliard RB, Son YI, Redlinger R, Coates PT, Giermasz A, Morel PA, Storkus WJ, Kalinski P.

J Immunol. 2003 Sep 1;171(5):2366-73.

16.

Recognition of virus-infected cells by natural killer cell clones is controlled by polymorphic target cell elements.

Malnati MS, Lusso P, Ciccone E, Moretta A, Moretta L, Long EO.

J Exp Med. 1993 Sep 1;178(3):961-9.

17.

Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome.

Caligiuri M, Murray C, Buchwald D, Levine H, Cheney P, Peterson D, Komaroff AL, Ritz J.

J Immunol. 1987 Nov 15;139(10):3306-13.

PMID:
2824604
18.

Defective NK cell activity following thermal injury.

Klimpel GR, Herndon DN, Fons M, Albrecht T, Asuncion MT, Chin R, Stein MD.

Clin Exp Immunol. 1986 Nov;66(2):384-92.

20.

In vivo antiviral effect of interleukin 18 in a mouse model of vaccinia virus infection.

Tanaka-Kataoka M, Kunikata T, Takayama S, Iwaki K, Ohashi K, Ikeda M, Kurimoto M.

Cytokine. 1999 Aug;11(8):593-9.

PMID:
10433806

Supplemental Content

Support Center